Avoro Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Scribe is a molecular engineering company developing CRISPR-based genetic therapies to treat cardiometabolic disease and other conditions.
BiotechDeep TechHealthtechMedical DevicesBerkeley, US
Benjamin Oakes(Founder & CEO)Jennifer A. Doudna, PhD(Co-founder, Scientific Advisor)Benjamin L. Oakes, PhD(Co-founder, President and CEO)David F. Savage, PhD(Co-founder, Scientific Advisor)Brett Staahl, PhD(Co-founder, VP of External Innovation)
BoardVijay Pande(Director)in
Board seatBehzad Aghazadeh· per SEC Form D · $100M raise · filed Apr 2021
Co-investorsAndreessen HorowitzOrbiMedAvoro Capital AdvisorsMenlo VenturesRA Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.